Cargando…
Metabolic Checkpoints: Novel Avenues for Immunotherapy of Cancer
Novel therapies targeting immune checkpoint molecules have redefined the treatment of cancer at advanced stages and brought hope to millions of patients worldwide. Monoclonal antibodies targeting immune-inhibitory receptors often lead to complete and objective responses as well as to durable progres...
Autores principales: | Shevchenko, Ivan, Bazhin, Alexandr V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090142/ https://www.ncbi.nlm.nih.gov/pubmed/30131808 http://dx.doi.org/10.3389/fimmu.2018.01816 |
Ejemplares similares
-
Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy
por: Bazhin, Alexandr V., et al.
Publicado: (2018) -
miR-aculous new avenues for cancer immunotherapy
por: Tang, William W., et al.
Publicado: (2022) -
Immune Checkpoints and Innate Lymphoid Cells—New Avenues for Cancer Immunotherapy
por: Jacquelot, Nicolas, et al.
Publicado: (2021) -
Ubiquitination in T-Cell Activation and Checkpoint Inhibition: New Avenues for Targeted Cancer Immunotherapy
por: Gavali, Shubhangi, et al.
Publicado: (2021) -
Diversity of immune checkpoints in cancer immunotherapy
por: Guo, Zhangyan, et al.
Publicado: (2023)